Home › Myeloproliferative Neoplasms › Vermont
Myeloproliferative Neoplasms clinical trials in Vermont
3 studies for Myeloproliferative Neoplasms are looking for participants at sites in Vermont.
Cities in Vermont
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 to 59 · All sexes · Updated Nov 9, 2026 · NCT05554406MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05564390Project: Every Child for Younger Patients With Cancer
- University of Vermont and State Agricultural College, Burlington
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.